Literature DB >> 11153806

Treatment guidelines: current and future management of bipolar disorder.

J F Goldberg1.   

Abstract

The emergence of new treatments for bipolar disorder has coincided with a proliferation of published treatment algorithm recommendations and practice guidelines. Several guidelines derive from critical appraisals of current treatment literature and, as such, may serve as a critical reference resource to complement individual clinical judgment. This review describes points of overlap and discordance across currently available treatment guidelines for bipolar disorder and presents common clinical situations in which the consultation of treatment guidelines may provide clinicians with useful information and a rationale for making sequential treatment decisions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11153806

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  10 in total

Review 1.  The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.

Authors:  Konstantinos N Fountoulakis; Lakshmi Yatham; Heinz Grunze; Eduard Vieta; Allan Young; Pierre Blier; Siegfried Kasper; Hans Jurgen Moeller
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176

Review 2.  Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry.

Authors:  Konstantinos N Fountoulakis; Siegfried Kasper; Ole Andreassen; Pierre Blier; Ahmed Okasha; Emanuel Severus; Marcio Versiani; Rajiv Tandon; Hans-Jürgen Möller; Eduard Vieta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-06       Impact factor: 5.270

3.  Bipolar-I depression outpatient treatment quality and costs in usual care practice.

Authors:  Alisa B Busch; Richard G Frank; Gary Sachs
Journal:  Psychopharmacol Bull       Date:  2008

4.  Brain lithium levels and effects on cognition and mood in geriatric bipolar disorder: a lithium-7 magnetic resonance spectroscopy study.

Authors:  Brent P Forester; Chris C Streeter; Yosef A Berlow; Hua Tian; Megan Wardrop; Chelsea T Finn; David Harper; Perry F Renshaw; Constance M Moore
Journal:  Am J Geriatr Psychiatry       Date:  2009-01       Impact factor: 4.105

5.  [Drug therapy of acute manias. A retrospective data analysis of inpatients from 1997 to 1999].

Authors:  M Letmaier; D Schreinzer; N Thierry; R Wolf; S Kasper
Journal:  Nervenarzt       Date:  2004-03       Impact factor: 1.214

6.  A comparison of the life goals program and treatment as usual for individuals with bipolar disorder.

Authors:  Martha Sajatovic; Marilyn A Davies; Stephen J Ganocy; Mark S Bauer; Kristin A Cassidy; Robert W Hays; Roknedin Safavi; Frederic C Blow; Joseph R Calabrese
Journal:  Psychiatr Serv       Date:  2009-09       Impact factor: 3.084

Review 7.  Costs of bipolar disorder.

Authors:  Leah Kleinman; Ana Lowin; Emuella Flood; Gian Gandhi; Eric Edgell; Dennis Revicki
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

8.  Bipolar disorder: clinical perspectives and implications with cognitive dysfunction and dementia.

Authors:  R Lopes; L Fernandes
Journal:  Depress Res Treat       Date:  2012-05-28

9.  Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder.

Authors:  Konstantinos N Fountoulakis; Eduard Vieta; Melina Siamouli; Marc Valenti; Stamatia Magiria; Timucin Oral; David Fresno; Panteleimon Giannakopoulos; George S Kaprinis
Journal:  Ann Gen Psychiatry       Date:  2007-10-09       Impact factor: 3.455

Review 10.  The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 3: The Clinical Guidelines.

Authors:  Konstantinos N Fountoulakis; Heinz Grunze; Eduard Vieta; Allan Young; Lakshmi Yatham; Pierre Blier; Siegfried Kasper; Hans Jurgen Moeller
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.